|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 1 March 2005
doi: 10.1242/jcs.01704
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
Np73
via p53 specifically in neuroblastoma cells

1 CNRS UMR 8126, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France
2 INSERM U590, Centre Leon Bérard, 28 rue Laënnec, 69008 Lyon, France
3 CEA-CNRS UMR217, PB6, 92265 Fontenay-aux-Roses, France
Author for correspondence (e-mail: sdouc{at}igr.fr)
Accepted 6 January 2005
The p53 gene and its homologue p73 are rarely mutated in neuroblastoma. In recent studies, we showed that overexpression of
Np73
, an isoform lacking the N-terminal transactivation (TA) domain, surprisingly induces p53 protein accumulation in the wild-type (wt) p53 human neuroblastoma line SH-SY5Y. As can be expected owing to its dominant-negative effect,
Np73
inhibits Waf1/p21 gene expression, but equally importantly, it upregulates BTG2TIS21/PC3, another p53 target gene. This effect is not observed in neuroblastoma cells that express a mutated p53. To better understand the
Np73-mediated transactivation of the BTG2TIS21/PC3 gene we performed luciferase assays with two reporter plasmids harboring long and short BTG2 promoter sequences in three human neuroblastoma cell lines and one breast cancer cell line. Our results demonstrate that BTG2TIS21/PC3 transactivation by
Np73
depends on both p53 status (as it is not observed in a p53/ neuroblastoma cell line) and cellular context (as it occurs in a p53+/+ neuroblastoma cell line but not in a p53+/+ breast tumor cell line). The fact that
Np73
may either inhibit or stimulate wt-p53 transcriptional activity, depending on both the p53 target gene and the cellular context, was confirmed by real-time quantitative PCR. Moreover, transactivation of the BTG2TIS21/PC3 promoter requires a complete
Np73
C-terminus sequence as it is not observed with
Np73ß, which lacks most of the C-terminal domain. We have previously shown that
Np73
is the only p73 isoform expressed in undifferentiated neuroblastoma tumors. In light of all these findings, we propose that
Np73
not only acts as an inhibitor of p53/TAp73 functions in neuroblastoma tumors, but also cooperates with wt-p53 in playing a physiological role through the activation of BTG2TIS21/PC3 gene expression.
Key words: p73, p53, BTG2TIS21/PC3, Transactivation, Neuroblastoma, Apoptosis, Differentiation, Development
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
F. Marques-Garcia, N. Ferrandiz, R. Fernandez-Alonso, L. Gonzalez-Cano, M. Herreros-Villanueva, M. Rosa-Garrido, B. Fernandez-Garcia, J. P. Vaque, M. M. Marques, M. E. Alonso, et al. p73 Plays a Role in Erythroid Differentiation through GATA1 Induction J. Biol. Chem., August 7, 2009; 284(32): 21139 - 21156. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Horvilleur, M. Bauer, D. Goldschneider, X. Mergui, A. de La Motte, J. Benard, S. Douc-Rasy, and D. Cappellen p73{alpha} isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells Nucleic Acids Res., August 1, 2008; 36(13): 4222 - 4232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang and X. Chen {Delta}Np73 Modulates Nerve Growth Factor-Mediated Neuronal Differentiation through Repression of TrkA Mol. Cell. Biol., May 15, 2007; 27(10): 3868 - 3880. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goldschneider, E. Horvilleur, L.-F. Plassa, M. Guillaud-Bataille, K. Million, E. Wittmer-Dupret, G. Danglot, H. d. The, J. Benard, E. May, et al. Expression of C-terminal deleted p53 isoforms in neuroblastoma Nucleic Acids Res., November 14, 2006; 34(19): 5603 - 5612. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Bourdon, K. Fernandes, F. Murray-Zmijewski, G. Liu, A. Diot, D. P. Xirodimas, M. K. Saville, and D. P. Lane p53 isoforms can regulate p53 transcriptional activity Genes & Dev., September 15, 2005; 19(18): 2122 - 2137. [Abstract] [Full Text] [PDF] |
||||